Sensus Healthcare (SRTS) Reports Q2 Loss of $0.02

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Sensus Healthcare (SRTS) Reports Q2 Loss of $0.02

Sensus Healthcare Reports Second Quarter 2016 Results

August 4, 2016 4:05 PM EDT

BOCA RATON, Fla., Aug. 4, 2016 /PRNewswire/ -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today reported its financial results for the second quarter ended June 30, 2016.

Recent Business Highlights

Successfully completed Initial Public Offering on June 2, 2016 raising net proceeds of $10.4 million Expanded sales team to 12 experienced employees during the quarter, with specializations in dermatology and radiation oncology Sold 14 systems during the quarter, increasing worldwide... More